Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dependence-related screening positivity among regular stimulant-laxative users with chronic constipation: a multicenter prospective observational study.

Journal of gastroenterology·2026
Same author

Impact of Chronic Constipation and Subtypes on Serum Trimethylamine-N-Oxide Levels and Their Reduction With Treatment: Multicenter Observational Study.

Clinical and translational gastroenterology·2026
Same author

Therapeutic Impact on Quality of Life in Adult Patients With Chronic Intestinal Pseudo-obstruction: A Multicenter, Cohort Study.

Journal of neurogastroenterology and motility·2026
Same author

Multifocal Inflammatory Myofibroblastic Tumor Presenting With Hemorrhagic Shock Due to Duodenal Invasion by a Pancreatic Head Mass: A Case Report.

Cureus·2026
Same author

Advancing Antibody Titer Assessment in ABO-Incompatible Transplantation.

Antibodies (Basel, Switzerland)·2025
Same author

Late-Onset Bone Metastasis 46 Years After Initial Surgery for Pheochromocytoma: A Case Report.

IJU case reports·2025

Related Experiment Video

Updated: May 19, 2026

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
09:15

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach

Published on: May 7, 2019

ABO-incompatible kidney transplantation.

Kota Takahashi1, Kazuhide Saito

  • 1Division of Urology, Department of Regenerative and Transplant Medicine, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan. kota@med.niigata-u.ac.jp

Transplantation Reviews (Orlando, Fla.)
|August 21, 2012
PubMed
Summary
This summary is machine-generated.

ABO-incompatible kidney transplantation (ABO-IKTx) in Japan has achieved high success rates, comparable to ABO-compatible transplants. Preoperative desensitization therapy is crucial for preventing acute antibody-mediated rejection and improving outcomes in ABO-IKTx.

More Related Videos

Mouse Kidney Transplantation: Models of Allograft Rejection
16:15

Mouse Kidney Transplantation: Models of Allograft Rejection

Published on: October 11, 2014

Related Experiment Videos

Last Updated: May 19, 2026

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
09:15

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach

Published on: May 7, 2019

Mouse Kidney Transplantation: Models of Allograft Rejection
16:15

Mouse Kidney Transplantation: Models of Allograft Rejection

Published on: October 11, 2014

Area of Science:

  • Nephrology
  • Transplantation Immunology
  • Surgical Innovation

Background:

  • Shortage of deceased organ donors in Japan necessitates alternative transplantation methods.
  • Living donor kidney transplantation (LDKTx) is expanded through ABO-incompatible procedures (ABO-IKTx).
  • Approximately 2000 ABO-IKTx procedures performed since 1989.

Purpose of the Study:

  • To evaluate the outcomes of ABO-IKTx in Japan.
  • To elucidate the mechanisms of acute antibody-mediated rejection (AMR) in ABO-IKTx.
  • To identify strategies for improving ABO-IKTx success rates.

Main Methods:

  • Analysis of clinical outcomes for ABO-IKTx performed over two decades.
  • Proteomic analysis of ABO histo-blood group antigens in graft endothelial cells.
  • Immunological and biological investigations into AMR development.

Main Results:

  • 1-year graft survival: 96%, 5-year: 91%, 9-year: 83% for ABO-IKTx since 2001.
  • Outcomes are comparable to ABO-compatible kidney transplantation (ABO-CKTx).
  • ABO-IKTx now constitutes ~30% of all LDKTx in Japan.

Conclusions:

  • ABO-IKTx is an accepted therapeutic alternative for end-stage renal failure.
  • Structural differences in ABO antigens and de novo antibody production are hypothesized to drive AMR.
  • Preoperative desensitization therapy is key to suppressing AMR and improving graft survival.